A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis

Journal of Dermatological Treatment

Volumn 18, Issue 5, 2007, Pages 286-290

  Yoon, Hyun Sun ^a   Youn, Jai Il ^a  

^a Seoul National University   (South Korea)

Author keywords

Cyclosporine; Psoriasis; Step down regimen

Indexed keywords

CIPOL N; CYCLOSPORIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERTROPHY; HEMATURIA; HUMAN; HYPERTRICHOSIS; HYPERURICEMIA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN; TREATMENT OUTCOME;

EID: 35148896887     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701418747     Document Type: Article

References (16)

1. Mueller W, Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979;301:555.
2. Griffiths CEM, Dubertret L, Ellis CN, Finlay AY, Finzi AF, HO VC, et al. Ciclosporin in psoriasis clinical practice: An international consensus statement. Br J Dermatol. 2004;150(suppl 67):11-23.
3. Youn JI, Moon SE, Kim DW, Park ES, Moon DC, Kim YK, et al. Cyclosporine in the treatment of psoriasis. J Dermatol Treat. 1993;4:123-6.
4. Choi JH, Kim KJ, Kim NI, Kim TY, Park KB, Youn JI. Multicenter clinical study to evaluate the efficacy and safety of microemulsion cyclosporine (Cipol-N®) in the treatment of psoriasis. Korean J Clin Pharmacol Ther. 2002;8:184-95.
5. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patients-membership survey. Arch Dermatol. 2001;137:280-4.
6. Finlay AY, Orthone JP. Patient satisfaction with psoriasis therapies: An update and introduction to biologic therapy. J Cutan Med Surg. 2004;8:310-20.
7. Finlay AY. Psoriasis from the patient's point of view. Arch Dermatol. 2001;137:352-3.
8. Timonen P, Friend D, Abeywickrama K, Laburte C, von Graffenried B, Feutren G. Efficacy of low-dose cyclosporin A in psoriasis: Results of dose-finding studies. Br J Dermatol. 1990;122(suppl 36):33-9.
9. Laburte C, Grossman R, Abi-Rached J, Abeywickrama KH, Dubertret L. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun®) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol. 1994;130:366-75.
10. Ellis CN, Fradin MS, Messana JM, Brown MD, Siegel MT, Voorhees JJ, et al. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med. 1991;324:277-84.
11. Feutren G, Abeywickrama K, Friend D, von Graffenried B. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Br J Dermatol. 1990;122(suppl 36):57-69.
12. Christophers E, Mrowietz U, Henneicke HH, Farber L, Welzel D. Cyclosporine in psoriasis: A multicenter dose-finding study in severe plaque psoriasis. The German multicenter study. J Am Acad Dermatol. 1992;26:86-90.
13. Ho VC, Albrecht G, Vanaclocha F, Leon-Dorantes G, Atakan N, Reitamo S, et al. Intermittent short courses of cyclosporin (Neoral®) for psoriasis unresponsive to topical therapy: A 1-year multicenter, randomized study. Br J Dermatol. 1999;141:283-91.
14. Faerber L, Braeutigam M, Weidinger G, Mrowietz U, Christophers E, Schulze HJ, et al. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. Am J Clin Dermatol. 2001;2:41-7.
15. Lowe NJ, Wieder JM, Rosenbach A, Johnson K, Kunkel R, Bainbridge C, et al. Long-term low-dose cyclosporine therapy for severe psoriasis: Effects on renal function and structure. J Am Acad Dermatol. 1996;35:710-19.
16. Mihatsch MJ, Belghiti D, Bohman SO, Porter K, Dubertret L, Feutren G, et al. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun®) in Autoimmune Diseases. Br J Dermatol. 1990;122(suppl 36):95-100.